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1041-11 Significant Association of Renin-Angiotensin System 
Gene Polymorphisms With Human Atrial Fibrillation 
Chia-Ti Tsai, Ling-Ping Lai, Fu-Tien Chiang, Jiunn-Lee Lin, Yung-Zu Tseng. National 
Taiwan University Hospital, Taipei, Taiwan.ROC 
Background Activated local atrial renin-angiotensin system (RAS) has been reported to 
play an important role in the pathogenesis of Afib. We hypothesized that the RAS genes 
might be among the susceptible genes of Afib, and conducted a genetic case-control 
study to demonstrate this. Methods and Results A total of 110 patients with docu- 
mented Afib and 110 controls were selected. The controls were matched to cases one- 
by-one regarding age, sex, presence of left ventricular dysfunction, and presence of sig- 
nificant valvular heart disease. Angiotensin-cotwelting enzyme gene insertion/deletion 
polymorphism: T174M, M235T. G-6A. A-20C, G-152A, and G-217A polymorphisms of 
the angiotensinogen gene: and A1166C polymorphism of the angiotensin II type I recep- 
tor gene were genotyped. In single-locus analysis, M235T, G-6A, and G-217A were sig- 
nificantly associated with Afib. The frequencies of M235, G-6, and G-217 alleles were 
significantly higher in cases than in controls (EO.001, 0.005, and 0.039, respectively). 
The odds ratios for Afib were 3.3 (95% confidence interval [Cl] 1.4-10.0) with M235/M235 
plus M2351T235 genotype, 2.0 (95% Cl 1.1-5.0) with G-6/G-6 plus G-6/A-6 genotype, 
and 2.0 (95% Cl 1.1-5.0) with G-217/G-217 genotype. The associations were significant 
and not random, and could be explained by our relevant functional studies. In multilocus 
haplotype analysis, the angiotensinogen gene haplotype profile was significantly different 
between casas and controls ($=35.5, kO.034). NO significant gene-gene interaction 
was noted by stratification analysis and multivariate analysis. Conc/uslons Our study 
first demonstrates the significant association of RAS gene polymorphisms with Afib. and 
may provide the rationale for clinical trials to investigate the use of angiotensin converting 
enzyme inhibitor or angiotensin II antagonist in the treatment of Afib. 
1041-12 Ability of Activation Recovery Interval to Assess 
Electrical Restitution Properties 
Jian Huanq Robert K. Justice, Dennis L. Rollins, Gregory P. Walcott, Raymond E. 
Ideker. University of Alabama at Birmingham, Birmingham, AL 
Background: Electrical restitution properties have been proposed as a mechanism for 
the development of altemans and ventricular arrhythmias. The measurement of restitu- 
tion curves is mainly based on data from monophasic action potentials (MAP), optical, 
and micro-electrode recordings. We investigated if activation recovery intervals (ARI) 
determined from unipolar electrograms have a similar ability to assess restitution proper- 
ties. 
Methods: Needles containing 3 KCI MAP electrodes 5 mm apart, each consisting of a 
KCI electrode and a nearby reference electrode, were inserted into the anterior left ven- 
tricular free wall to record transmurally in 6 open-chest pigs. We calculated action poten- 
tial duration (APD), and ARI at pacing rates from 400 to 120 ms. APD, was defined as 
the interval from the onset of the action potential to the time for the action potential return 
to 90% of its maximum value in the MAP electrode recording after the last Sl stimulus. 
ARI was determined from unipolar recordings of the reference electrode of each MAP 
electrode pair and defined as the interval between the maximum negative dV/dt of the 
QRS complex and maximum positive dV/dt of the T wave. Restitution curves were sig- 
moidal functions fit to these two sets of data. 
Results: The ARI value closely correlated with the APD 9o measurements during the dif- 
ferent pacing rates (rcO.94, peO.001). The slopes for ARI and APDgo restitution curves 
were also correlated closely (r=0.96, p<O.OOl). 
Conclusion : ARls obtained from unipolar electrograms provide an accurate assessment 
of changes in APD at different pacing rates. Thus, the restitution CUIVVBS generated from 
ARI measurements are similar to those from MAP measurements. This demonstrates the 
practical usefulness of the unipolar electrogram as a tool for assessing the spatial dlstri- 
bution of restitution properties as well as activation sequences. 
1041-13 Inhibition of Calcium Overload by lntrapericardial 
Nitroglycerin as a Major Mechanism for Its Potent 
Antifibrillatory Effect 
Susan X. Zhao, Veronica 0. Busso, Bruce D. Nearing, Kapil Kumar, Richard L. Verrier, 
Harvard Medical School-MIT Division of Health Sciences &Technology, Boston. MA, 
Beth Israel Deaconess Medical Center, Boston, MA 
Background: lntrapericardial (IPC) nitroglycerin (NTG), a potent nitric oxide (NO) donor, 
prevents ischemia-induced ventricular fibrillation in pigs. We hypothesized that a main 
mechanism of this protection is the capacity of NO to reduce the profibrillatory effects of 
ischemia-induced intracellular calcium overload. 
Methods: In 8 closed-chest anesthetized pigs, calcium overload was induced directly by 
C&I, (50-mg boluses) injection into the left main coronary artery both before and at 15. 
min intervals after IPC NTG delivery through a transatrial catheter. Similarly, in another 4 
pigs, 60-SEC angioplasty-balloon inflation of the LAD was performed to induce &hernia 
associated calcium overload. Vulnerability was measured by T-wave dispersion in pre- 
cordial electrograms using root-mean-square morphology analysis. Vagotomy and meto- 
prolol (1.5 mg/kg, bolus) were employed to preclude autonomic influences. 
Results: IPC NTG significantly blunted calcium-induced dispersion, with a maximum 
effect at 45 min post-drug. IPC NTG also reduced ischemia-induced dispersion by 30% 
with a parallel time course. (‘~~0.05). 
Conclusion: IPC NTG is capable of blunting both calcium- and ischemia-induced disper- 
sion of repolarization. consistent with its previously demonstrated antifibrillatoty effect. 
Because calcium overload is a significant factor in ischemia-induced arrhythmia, NTG’s 
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ability to improve calcium handling appears to be a major mechanism of its protective 
action. 
1041-14 
caua &wa oaa(wlm rutQ 
Tyrosine Kinases Inhibit Availability and Open 
Probability of Single L-Type Calcium Channels in 
Human Atrial Myocytes 
Frank Schriider, Gunnar Klein, Tan@ Frank, Michaela Bastain. Helmut Drexler, Medical 
School of Hannover, Hannover, Germany 
Background: In human atrial myocytes, the L-type calcium current is essential for elec- 
tromechanical coupling and action potential duration. Rapid changes are caused by mod- 
ifications of single L-type calcium channel (LTCC) phosphorylation. A detailed analysis of 
the effect of tyrosine protein kinases (TK) on single cardiac LTCC gating has not yet 
been performed. Thus, the present study investigates the influence of TK on single 
human atrial LTCC regulation. Methods: Single LTCC were recorded in the cell-attached 
configuration of the patch clamp technique in isolated human atrial myocyies. Results: 
The TK-inhibitor genistein and the Src kinase inhibitor PPl significantly enhanced single 
LTCC peak average current (I) increasing availability (f3 and open probability (p,,) 
(genistein: I from l&36+ 5.77 to 30.34~ 6.46 fA, f,from 31.22+ 6.74 to 42.93* 4.63 %, p0 
from 5.03i 1.43 to 5.57+ 2.04 %, PPl: I from 14.13i 3.46 to 31.7+ 5.81 fA, f, from 
55.95* 5.78 to 86.66* 3.03 %, p0 from 2.09* 0.92 to 4.05+ 0.98 %) PP3, an inactive ana- 
logue of PPl, did not influence these gating parameters. Furthenore, bisperoxo- 
phenanthroline-vanadate, a tyrosin phosphatase inhibitor significantly decreased I (from 
29.88a 4.91 to 12.84* 3.01 fA), & (from 53.29r 8.4 to 36.16+ 77.01 %), ~b (from 6.62+ 
1.77 to 3.86+ 1.57 %). Activation or inhibition of proteinkinase A by 8Br-CAMP or 
RPBBrPETcAMPs as well as inhibition of protein phosphatase I and Ila by okadaic acid 
did not influence the effect of TK on single LTCC activity. However, although genistein 
increased LTCC activity in the presence of the proteinkinase C (PKC) activator PMA, the 
effect of genistein was abated in the presence of the PKC inhibitors staurosporin or bisin- 
doylmaleimide. 
Conclusion: In human atrial myocytes. LTCC availability and open probability are under 
control of TK, particularly of the Src-family. Fwthermore, our results suggest that TK 
inhibit human atrial LTCC activity cooperatively with PKC. 
1041-15 The HMG-CoA Reductase Inhibitor Atorvastatin 
Prevents Atrial Fibrillation by Inhibiting Inflammation in 
the Canine Sterile Pericardltis Model 
Koichiro Kumaoai, Hideko Nakashima, Keijiro Saku, Fukuoka University, Fukuoka, 
Japan 
Background: HMG-CoA reductase inhibitors reduce C-reactive protein (CRP) levels. It 
has been recently reported that atrial fibrillation (AF) is associated with tissue inflamma- 
tion, and CRP is elevated in AF patients. We hypothesized that a statin could anenuate 
the progression of AF in the canine sterile pericarditis model. Methods and Results: 
Sterile pericarditis was created in 12 dogs, which were randomly assigned to two groups: 
control group (6 dogs) and atolvastatin treatment group (6 dogs). Atowastatin was 
administered orally (lOmg/kg/day) from 1 week before the operation to throughout the 
study. Before and 2 days after the operation, the CRP level, duration of induced AF, atrial 
effective refractory period (AERP) of the right atrial appendage, and intra-atrial conduc- 
tion time were determined. Before the operation, there were no significant differences in 
any of the parameters between the 2 groups. On the 2nd postoperative day, CRP was 
significantly lower in the atowastatin group than in the control (Table). Sustained (~600 
set) AF was induced in all dogs in the control group, but in only 1 dog in the atorvastatin 
group. The atorvastatin group had a shorter AF duration, a longer AERP, and a shorter 
intra-atrial conduction time than the control (Table). Conclusions: Atorvastatin can pre- 
vent the promotion of AF by inhibiting inflammation in the canine sterile pericarditis 
model. Atorvastatin may be a novel therapeutic agent for AF. 
CRP (mg/dL) 
AF duration (set) 
AERP (msec) 
Conduction time 
(msec) 
Control 
Before 
operation 
0.1+0.2 
5.5i4.2 
140+10 
44+11 
After 
operation 
11.8i1.3 
540t351 
1224 
56*7 
Atorvastatin 
Before 
operation 
0.1+0.3 
6.1k4.6 
142+10 
42+11 
After 
operation 
8.2*0.6” 
82&4* 
139*13’ 
46+5’ 
* p-=0.05, ** pcO.001 compared with control. 
